Posted by Arine,
Jul 20, 2026
Why medication adherence and optimization remain essential for health outcomes, cost savings, and quality performance. The recent court ruling in Clover Insurance Co. v. HHS has sparked widespread discussion across the Medicare Advantage industry. Much of the conversation ...
Posted by Arine,
Mar 06, 2026
Polypharmacy — defined as the concurrent use of five or more prescription medications — has become one of the most pressing ...
For all the progress made in shifting the U.S. healthcare system toward value-based care, one of the most powerful levers ...
With the release of CMS Star Ratings for 2026 and updates for the upcoming year, Medicare Advantage and Part D plans are ...
Posted by Arine,
Dec 16, 2025
Stay ahead of 2026 CMS Part D measure changes. Hear from Dr. Saba Syed on proposed updates and steps Medicare Advantage ...
Posted by Arine,
Oct 15, 2025
Prepare Now for MY2026 and Beyond Updated January 6, 2026 Medicare Advantage (MA) now serves over half of all Medicare ...
Artificial intelligence (AI) has dominated conversations among health plans and providers, given its potential to transform ...
Posted by Arine,
Aug 21, 2025
What is Fueling Arine’s Growth? We’re Solving a Massive, Urgent Healthcare Challenge Arine has, for the second consecutive ...
Posted by Arine,
Aug 12, 2025
AI-Powered Medication Intelligence Company Ranks No. 432 Overall and No. 16 in the Artificial Intelligence and Data ...
Posted by Arine,
Aug 01, 2025
World Economic Forum honors Arine for groundbreaking innovation in AI-driven medication optimization and its impact on ...
/ARINE_Primary_Color.png?width=221&height=50&name=ARINE_Primary_Color.png)